Detalhe da pesquisa
1.
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
N Engl J Med
; 387(7): 599-610, 2022 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36070710
2.
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019.
Clin Infect Dis
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38690892
3.
Framework of the Strengths and Challenges of Clinically Integrated Trials: An Expert Panel Report.
Am Heart J
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795793
4.
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial.
Clin Infect Dis
; 76(3): e1-e9, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124697
5.
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence.
Curr Diab Rep
; 23(8): 207-216, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37284921
6.
A method for comparing multiple imputation techniques: A case study on the U.S. national COVID cohort collaborative.
J Biomed Inform
; 139: 104295, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36716983
7.
Care of the Patient After Metabolic and Bariatric Surgery.
Ann Intern Med
; 175(5): ITC65-ITC80, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533387
8.
Obesity Management in Adults: A Review.
JAMA
; 330(20): 2000-2015, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015216
9.
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 329(4): 296-305, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633838
10.
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
JAMA
; 330(24): 2354-2363, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976072
11.
BMI metrics and their association with adiposity, cardiometabolic risk factors, and biomarkers in children and adolescents.
Int J Obes (Lond)
; 46(2): 359-365, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718333
12.
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 328(16): 1595-1603, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269852
13.
mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses.
J Med Virol
; 93(4): 1843-1846, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314219
14.
Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity.
J Med Virol
; 93(7): 4273-4279, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580540
15.
Patient Recruitment Into a Multicenter Clinical Cohort Linking Electronic Health Records From 5 Health Systems: Cross-sectional Analysis.
J Med Internet Res
; 23(5): e24003, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34042604
16.
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply.
N Engl J Med
; 387(24): e65, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516100
17.
Understanding Primary Care Patients' Self-weighing Habits: Cohort Analysis from the PaTH Clinical Data Research Network.
J Gen Intern Med
; 34(9): 1775-1781, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31313111
18.
Treatment of Obesity in Patients With Diabetes.
Diabetes Spectr
; 30(4): 237-243, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29151713
19.
SMART use of medications for the treatment of adolescent severe obesity: A sequential multiple assignment randomized trial protocol.
Contemp Clin Trials
; 138: 107444, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219798
20.
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial.
medRxiv
; 2024 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38798524